Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy

Molecular Biology Reports

Volumn 40, Issue 4, 2013, Pages 2963-2967

  Hu, Peng ^a   Xuan, Qiang ^a   Hu, Bo ^a   Lu, Ling ^a   Qin, Yuan Han ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Glomerular basement membrane; Membranous nephropathy; Natriuretic peptides; Neutral endopeptidase

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ENZYME ANTIBODY; MEMBRANE METALLOENDOPEPTIDASE; NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C; NEUTRAL ENDOPEPTIDASE ANTIBODY; PEPTIDE; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL DAMAGE; DISEASE COURSE; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR MATRIX; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOPATHOGENESIS; KIDNEY BLOOD FLOW; MEMBRANOUS GLOMERULONEPHRITIS; MICROCIRCULATION; MOLECULAR PATHOLOGY; NONHUMAN; PODOCYTE; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEINURIA;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIGEN-ANTIBODY COMPLEX; GLOMERULAR BASEMENT MEMBRANE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY GLOMERULUS; NATRIURETIC PEPTIDES; NEPRILYSIN; PROTEINURIA;

EID: 84878413227     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2367-4     Document Type: Article

References (44)

1. Cybulsky AV (2011) Membranous nephropathy. Contrib Nephrol 169:107-125
2. Heymann W, Hackel DB, Harwood S, Wilson SG, Hunter JL (1959) Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 100:660-664
3. Ronco P, Debiec H (2007) Target antigens and nephritogenic antibodies in membranous nephropathy: of rats and men. Semin Immunopathol 29:445-458
4. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM (2002) Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346:2053-2060
5. Jalal F, Lemay G, Zollinger M, Berteloot A, Boileau G, Crine P (1991) Neutral endopeptidase, a major brush border protein of the kidney proximal nephron, is directly targeted to the apical domain when expressed in Madin-Darby canine kidney cells. J Biol Chem 266:19826-19832
6. Ebihara F, Di Marco GS, Juliano MA, Casarini DE (2003) Neutral endopeptidase expression in mesangial cells. J Renin Angiotensin Aldosterone Syst 4:228-233
7. Hashimoto S, Amaya F, Oh-Hashi K, Kiuchi K, Hashimoto S (2010) Expression of neutral endopeptidase activity during clinical and experimental acute lung injury. Respir Res 11:164
8. Debiec H, Guigonis V, Mougenot B, Haymann JP, Bensman A, Deschênes G, Ronco PM (2003) Antenatal membranous glomerulonephritis with vascular injury induced by anti-neutral endopeptidase antibodies: toward new concepts in the pathogenesis of glomerular diseases. J Am Soc Nephrol 14:S27-S32
9. Prunotto M, Carnevali ML, Candiano G, Murtas C, Bruschi M, Corradini E, Trivelli A, Magnasco A, Petretto A, Santucci L, Mattei S, Gatti R, Scolari F, Kador P, Allegri L, Ghiggeri GM (2010) Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 21:507-519
10. Nangaku M, Shankland SJ, Couser WG (2005) Cellular response to injury in membranous nephropathy. J Am Soc Nephrol 16:1195-1204
11. Hong Y, Turner AJ (2007) Old enzyme with new interest: review of newly understood NEP functions and its potential regulators. Chin J Biochem Mol Biol 23:85-92
12. Baxter GF (2004) The natriuretic peptides. Basic Res Cardiol 99:71-75
13. Woodard GE, Rosado JA (2007) Recent advances in natriuretic peptide research. J Cell Mol Med 11:1263-1271
14. Kuhn M (2004) Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol 99:76-82
15. Hu P, Lu L, Hu B, Qin YH (2010) Renal action of C-type natriuretic peptide: advocating the isolated perfused rat kidney model. Saudi J Kidney Dis Transpl 21:613-620
16. Marumo F, Sakamoto H, Ando K, Ishigami T (1990) Concentrations of atrial natriuretic peptide in plasma and urine of kidney disease patients. Clin Chem 36:1650-1653
17. Shin SJ, Wen JD, Lee YJ, Chen IH, Tsai JH (1998) Increased C-type natriuretic peptide mRNA expression in the kidney of diabetic rats. J Endocrinol 158:35-42
18. Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, Bellanuova I, Tripepi R, Seminara G, Parlongo S, Stancanelli B, Bonanno G, Fatuzzo P, Rapisarda F, Belluardo P, Signorelli SS, Heublein DM, Lainchbury JG, Leskinen HK, Bailey KR, Redfield MM, Burnett JC Jr (2001) Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 76:1111-1119
19. Hu P, Wang J, Zhao XQ, Hu B, Lu L, Qin YH (2012) Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats. Mol Biol Rep. doi: 10.1007/s11033-012-2186-7
20. Cataliotti A, Giordano M, De Pascale E, Giordano G, Castellino P, Jougasaki M, Costello LC, Boerrigter G, Tsuruda T, Belluardo P, Lee SC, Huntley B, Sandberg S, Malatino LS, Burnett JC Jr (2002) CNP production in the kidney and effects of protein intake restriction in nephrotic syndrome. Am J Physiol Renal Physiol 283:F464-F472
21. Hu P, Wang J, Hu B, Lu L, Xuan Q, Qin YH (2012) Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis. Peptides 37:98-105
22. Ahluwalia A, MacAllister RJ, Hobbs AJ (2004) Vascular actions of natriuretic peptides. Cyclic GMP-dependent and -independent mechanisms. Basic Res Cardiol 99:83-89
23. Obineche EN, Adeghate E, Chandranath IS, Benedict S, Al Gafri LS, Adem A (2004) Alterations in atrial natriuretic peptide and its receptors in streptozotocin-induced diabetic rat kidneys. Mol Cell Biochem 261:3-8
24. Fonteles MC, Greenberg RN, Monteiro HS, Currie MG, Forte LR (1998) Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. Am J Physiol 275:F191-F197
25. Huxley VH, Tucker VL, Verburg KM, Freeman RH (1987) Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circ Res 60:304-307
26. Pham I, Sediame S, Maistre G, Roudot-Thoraval F, Chabrier PE, Carayon A, Adnot S (1997) Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Am J Physiol 273:R1457-R1464
27. Kiemer AK, Fürst R, Vollmar AM (2005) Vasoprotective actions of the atrial natriuretic peptide. Curr Med Chem Cardiovasc Hematol Agents 3:11-21
28. Sarker MH, Fraser PA (2002) The role of guanylyl cyclases in the permeability response to inflammatory mediators in pial venular capillaries in the rat. J Physiol 540:209-218
29. van Hinsbergh WM (1997) Endothelial permeability for macromolecules. Mechanistic aspects of pathophysiological modulation. Arterioscler Thromb Vasc Biol 17:1018-1023
30. Suenobu N, Shichiri M, Iwashina M, Marumo F, Hirata Y (1999) Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. Arterioscler Thromb Vasc Biol 19:140-146
31. Fürst R, Brueckl C, Kuebler WM, Zahler S, Krötz F, Görlach A, Vollmar AM, Kiemer AK (2005) Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ Res 96:43-53
32. Llorens-Cortes C, Huang H, Vicart P, Gasc JM, Paulin D, Corvol P (1992) Identification and characterization of neutral endopeptidase in endothelial cells from venous or arterial origins. J Biol Chem 267:14012-14018
33. Levidiotis V, Power DA (2005) New insights into the molecular biology of the glomerular filtration barrier and associated disease. Nephrology (Carlton) 10:157-166
34. Cybulsky AV, Quigg RJ, Salant DJ (2005) Experimental membranous nephropathy redux. Am J Physiol Renal Physiol 289:F660-F671
35. Minto AW, Kalluri R, Togawa M, Bergijk EC, Killen PD, Salant DJ (1998) Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous nephropathy. Proc Assoc Am Physicians 110:207-217
36. Raats CJ, Luca ME, Bakker MA, Van Der Wal A, Heeringa P, Van Goor H, Van Den Born J, De Heer E, Berden JH (1999) Reduction in glomerular heparan sulfate correlates with complement deposition and albuminuria in active Heymann nephritis. J Am Soc Nephrol 10:1689-1699
37. McMillan JI, Riordan JW, Couser WG, Pollock AS, Lovett DH (1996) Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 97:1094-1101
38. Canaan-Kühl S, Ostendorf T, Zander K, Koch KM, Floege J (1998) C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo. Kidney Int 53:1143-1151
39. Osawa H, Yamabe H, Kaizuka M, Tamura N, Tsunoda S, Baba Y, Shirato K, Tateyama F, Okumura K (2000) C-Type natriuretic peptide inhibits proliferation and monocyte chemoattractant protein-1 secretion in cultured human mesangial cells. Nephron 86:467-472
40. Liu S, Ding J, Fan Q, Zhang H (2010) The activation of extracellular signal-regulated kinase is responsible for podocyte injury. Mol Biol Rep 37:2477-2484
41. Lewko B, Stepinski J (2002) Cyclic GMP signaling in podocytes. Microsc Res Tech 57:232-235
42. Rippe C, Rippe A, Larsson A, Asgeirsson D, Rippe B (2006) Nature of glomerular capillary permeability changes following acute renal ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol 291:F1362-F1368
43. Friedrich C, Endlich N, Kriz W, Endlich K (2006) Podocytes are sensitive to fluid shear stress in vitro. Am J Physiol Renal Physiol 291:F856-F865
44. Lewko B, Gołos M, Latawiec E, Angielski S, Stepinski J (2006) Regulation of cGMP synthesis in cultured podocytes by vasoactive hormones. J Physiol Pharmacol 57:599-610